Leading Biochemist Charles Brenner, Ph.D., Joins City of Hope as Chair of First Department Focused on Diabetes and Cancer Metabolism
Retrieved on:
Monday, August 24, 2020
Research, Hospitals, Genetics, Diabetes, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Charles Brenner, Diabetes, Research, Hospitals, Genetics, Diabetes, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, United States administrative law, United States federal banking legislation, Finance, Money, Economy, Corporate crime, Credit, Fair Credit Reporting Act, Rulemaking, Federal Trade Commission, Notice of proposed rulemaking, Dodd–Frank Wall Street Reform and Consumer Protection Act
Biochemist Charles Brenner , Ph.D., has joined City of Hope to lead the nations first research department focused on the intersection between cancer and diabetes.
Key Points:
- Biochemist Charles Brenner , Ph.D., has joined City of Hope to lead the nations first research department focused on the intersection between cancer and diabetes.
- As chair of City of Hopes new Department of Diabetes & Cancer Metabolism, Brenner and his team will focus on metabolic disturbances that underlie diabetes, cancer and their complications.
- He will also recruit additional faculty members working at the interface of diabetes and cancer.
- City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.